Myocyte Enhancer Factor 2C as a New Player in Human Breast Cancer Brain Metastases

Myocyte Enhancer Factor 2C as a New Player in Human Breast Cancer Brain Metastases

Myocyte enhancer factor 2C (MEF2C) is increasingly expressed in mice along with breast cancer brain metastases (BCBM) development. We aim to ascertain MEF2C expression in human BCBM, establish the relationship with disease severity, disclose the involvement of vascular endothelial growth factor rece...

Full description

Bibliographic Details
Main Authors: Sofia Galego, Linda Azevedo Kauppila, Rui Malhó, José Pimentel, Maria Alexandra Brito
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cells
Subjects:
breast cancer brain metastases
biomarker
β-catenin
myocyte enhancer factor 2C
proliferation
vascular endothelial growth factor receptor-2
Online Access:https://www.mdpi.com/2073-4409/10/2/378

Internet

https://www.mdpi.com/2073-4409/10/2/378

Similar Items